Raymond Barlow
Chief Executive Officer @Synox Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Chief Executive Officer @Synox Therapeutics
SynOx Therapeutics Limited is a Dublin, Ireland-based, late-stage clinical biopharmaceutical company developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for the treatment of tenosynovial giant cell tumours (TGCT) and other macrophage related disorders.\\\\nSynOx is led by an experienced team of industry professionals with a successful track record of developing and bringing products to commercialisation. It is backed by a strong syndicate of premier life science investors including HealthCap, Medicxi, Forbion and Gimv. Other shareholders include Celleron Therapeutics and Roche.\\\\n \\\\n\\\\n \\\\n \\\\n\\\\n \\\\n
SKILLS
ABOUT RAYMOND BARLOW
I am a C-Suite Commercial Business Leader and Corporate Business Development Expert…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.